March 14th According to the White House website, although other countries in Europe and the world called on the United States to provide its AstraZeneca vaccine, White House spokesman Pusaki stressed again on the 12th local time that the United States should first ensure that its people can be vaccinated, and said that the U.S. government has not provided the vaccine to any Country.
At the White House press conference, it was asked that more than 10 million doses of AstraZeneca vaccine in the United States could not be used, but if the company did not deliver these doses to the U.S. government, it could save lives in Europe and elsewhere. At present, AstraZeneca calls on the United States to allow them to export these vaccines. Why does the president disagree?
In response, Prusaki said that President Biden’s focus, as he has emphasized many times, is to ensure that the American people can be vaccinated. Biden announced a vaccination schedule in his speech on the evening of the 11th, so the United States should ensure that it can have enough doses to achieve the goal by the end of May.
Biden said at the time that adults in all states, tribes and territories would be eligible for vaccination by May 1.
AstraZeneca’s vaccine has not been approved by the U.S. Drug Administration, Pusagi said. We also want to make sure we have the greatest flexibility to make sure that our supply is abundant and well prepared, and that we have the ability to provide vaccines to the American people, regardless of which vaccine is the most effective.”
She stressed that there are still 1,400 deaths from COVID-19 every day in the United States, and there is a need to focus on solving this problem.
“At this time, there is demand all over the world,” Pussaki said. Of course, many countries have asked the United States to provide vaccines, and the U.S. government has not provided vaccines to anyone. She said that this has nothing to do with Europe, but with the priorities and priorities of the United States, which has been very open and clear.
